相似文献
1
Antioxidants and CVD in diabetes: where do we stand now.
Curr Diab Rep. 2007 Feb;7(1):8-13. doi: 10.1007/s11892-007-0003-9.
2
Sodium-glucose cotransporter inhibitors and oxidative stress: An update.
J Cell Physiol. 2019 Apr;234(4):3231-3237. doi: 10.1002/jcp.26760. Epub 2018 Nov 15.
3
Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice.
Cardiovasc Diabetol. 2005 Apr 29;4:5. doi: 10.1186/1475-2840-4-5.
4
Oxidative stress and antioxidant treatment in diabetes.
Ann N Y Acad Sci. 2004 Dec;1031:204-13. doi: 10.1196/annals.1331.020.
5
Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease.
Am J Cardiol. 2008 May 22;101(10A):58D-68D. doi: 10.1016/j.amjcard.2008.02.010.
6
Antioxidant capacities of flavones and benefits in oxidative-stress related diseases.
Curr Top Med Chem. 2015;15(2):105-19.
7
Antioxidants in the treatment of diabetes.
Curr Diabetes Rev. 2011 Mar;7(2):106-25. doi: 10.2174/157339911794940729.
8
Using insulin as a drug rather than as a replacement hormone during acute illness: a new paradigm.
Heart Dis. 2003 Sep-Oct;5(5):323-33. doi: 10.1097/01.hdx.0000089839.13906.63.
9
Glucose-induced endoplasmic reticulum stress is independent of oxidative stress: A mechanistic explanation for the failure of antioxidant therapy in diabetes.
Free Radic Biol Med. 2011 May 1;50(9):1140-3. doi: 10.1016/j.freeradbiomed.2011.02.002. Epub 2011 Feb 12.
10
PROOXIDANT ACTIVITIES OF ANTIOXIDANTS AND THEIR IMPACT ON HEALTH.
Acta Clin Croat. 2019 Dec;58(4):726-736. doi: 10.20471/acc.2019.58.04.20.
引用本文的文献
1
Challenging directions in pediatric diabetes - the place of oxidative stress and antioxidants in systemic decline.
Front Pharmacol. 2024 Dec 18;15:1472670. doi: 10.3389/fphar.2024.1472670. eCollection 2024.
2
In Vitro Anti-Oxidant, In Vivo Anti-Hyperglycemic, and Untargeted Metabolomics-Aided-In Silico Screening of Macroalgae Lipophilic Extracts for Anti-Diabetes Mellitus and Anti-COVID-19 Potential Metabolites.
Metabolites. 2023 Nov 27;13(12):1177. doi: 10.3390/metabo13121177.
3
6-Year trajectory of fasting plasma glucose (FPG) and mortality risk among individuals with normal FPG at baseline: a prospective cohort study.
Diabetol Metab Syndr. 2023 Aug 13;15(1):169. doi: 10.1186/s13098-023-01146-2.
4
Food Polyphenols and Type II Diabetes Mellitus: Pharmacology and Mechanisms.
Molecules. 2023 May 10;28(10):3996. doi: 10.3390/molecules28103996.
5
Detrimental Effects of Lipid Peroxidation in Type 2 Diabetes: Exploring the Neutralizing Influence of Antioxidants.
Antioxidants (Basel). 2022 Oct 20;11(10):2071. doi: 10.3390/antiox11102071.
6
Therapeutic Potential of Quercetin in the Management of Type-2 Diabetes Mellitus.
Life (Basel). 2022 Jul 28;12(8):1146. doi: 10.3390/life12081146.
7
Fabrication and Evaluation of Quercetin Nanoemulsion: A Delivery System with Improved Bioavailability and Therapeutic Efficacy in Diabetes Mellitus.
Pharmaceuticals (Basel). 2022 Jan 5;15(1):70. doi: 10.3390/ph15010070.
8
The Impact of New-Onset Diabetes Mellitus and Hypertension on All-Cause Mortality in an Apparently Healthy Population: A Ten-Year Follow-Up Study.
J Diabetes Res. 2021 Nov 5;2021:3964013. doi: 10.1155/2021/3964013. eCollection 2021.
9
Anti-Diabetic Effect of Cotreatment with Quercetin and Resveratrol in Streptozotocin-Induced Diabetic Rats.
Biomol Ther (Seoul). 2018 Mar 1;26(2):130-138. doi: 10.4062/biomolther.2017.254.
10
Aspalatone Prevents VEGF-Induced Lipid Peroxidation, Migration, Tube Formation, and Dysfunction of Human Aortic Endothelial Cells.
Oxid Med Cell Longev. 2017;2017:2769347. doi: 10.1155/2017/2769347. Epub 2017 Jan 24.
本文引用的文献
1
Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study.
JAMA. 2006 Sep 13;296(10):1255-65. doi: 10.1001/jama.296.10.1255.
2
Tetrahydrobiopterin and cardiovascular disease.
Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2439-44. doi: 10.1161/01.ATV.0000243924.00970.cb. Epub 2006 Aug 31.
3
Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
Diabetes Care. 2006 Sep;29(9):2064-71. doi: 10.2337/dc06-0531.
4
Advanced glycation end products: sparking the development of diabetic vascular injury.
Circulation. 2006 Aug 8;114(6):597-605. doi: 10.1161/CIRCULATIONAHA.106.621854.
5
Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling.
Diabetes. 2006 Aug;55(8):2231-7. doi: 10.2337/db06-0369.
6
Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women.
Arch Intern Med. 2006 Jun 26;166(12):1311-6. doi: 10.1001/archinte.166.12.1311.
7
Correction of endothelial dysfunction in diabetic female rats by tetrahydrobiopterin and chronic insulin.
J Vasc Res. 2006;43(4):309-20. doi: 10.1159/000093196. Epub 2006 May 8.
8
The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults.
Ann Intern Med. 2006 Apr 18;144(8):554-62. doi: 10.7326/0003-4819-144-8-200604180-00005.
9
Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes.
Curr Opin Pharmacol. 2006 Apr;6(2):136-41. doi: 10.1016/j.coph.2006.01.001. Epub 2006 Feb 17.
10
Increased vascular biosynthesis of tetrahydrobiopterin in apolipoprotein E-deficient mice.
Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2466-71. doi: 10.1152/ajpheart.00366.2005. Epub 2006 Jan 20.
Zotero 插件